Cigna modified MM 0510 for transthoracic echocardiography in adults, effective February 14, 2026. Here's what billing teams need to do.
Cigna Healthcare updated its transthoracic echocardiography coverage policy under MM 0510, affecting 10 CPT codes (93303, 93304, 93306, 93307, 93308, 93319, 93320, 93321, 93325, and 93356) and five HCPCS codes (C8921, C8922, C8923, C8924, and C8929) for adult patients age 18 and older. The policy governs non-stress TTE studies and maps to 444 ICD-10-CM diagnosis codes spanning cardiac, oncologic, infectious, and systemic conditions. If your practice bills echocardiography to Cigna for adult patients, this coverage policy directly affects your charge capture, documentation requirements, and exposure to claim denial.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Transthoracic Echocardiography in Adults |
| Policy Code | MM 0510 |
| Change Type | Modified |
| Effective Date | February 14, 2026 |
| Impact Level | High |
| Specialties Affected | Cardiology, Internal Medicine, Oncology, Infectious Disease, Critical Care, Pulmonology |
| Key Action | Audit documentation for all TTE claims billed to Cigna and confirm ICD-10 codes map to covered indications before submitting claims dated on or after February 14, 2026 |
Cigna Transthoracic Echocardiography Coverage Criteria and Medical Necessity Requirements 2026
The Cigna transthoracic echocardiography coverage policy under MM 0510 covers non-stress TTE for adult patients age 18 and older when medical necessity criteria are met. Every CPT and HCPCS code in this policy — from the complete congenital study under CPT 93303 to myocardial strain imaging under CPT 93356 — sits in the "Considered Medically Necessary when criteria are met" group. There are no blanket covered codes. Every claim requires a qualifying diagnosis.
The breadth of the ICD-10-CM list (444 codes) signals that Cigna has mapped this policy carefully. Cardiac infections like meningococcal endocarditis (A39.51), viral myocarditis (B33.22), and candidal endocarditis (B37.6) qualify. So do systemic conditions with cardiac involvement — Chagas' disease (B57.0, B57.2), toxoplasma myocarditis (B58.81), and syphilitic heart conditions (A52.00–A52.06). Oncology indications span malignant neoplasms of the heart and mediastinum (C38.0–C38.8) through Hodgkin and non-Hodgkin lymphomas.
The real issue with this policy is that "criteria met" is load-bearing language. Cigna is not offering open-ended TTE reimbursement. Your documentation has to connect the clinical picture to a covered ICD-10 code and support why the study was ordered.
Whether Cigna requires prior authorization for TTE under this policy depends on the specific plan. Commercial and employer-sponsored Cigna plans vary. Check the member's benefit plan before scheduling, especially for follow-up or limited studies under CPT 93308 — those are the codes that draw scrutiny when documentation is thin.
Coverage Indications at a Glance
| Indication Category | Status | Key CPT/HCPCS Codes | Notes |
|---|---|---|---|
| Complete TTE for congenital cardiac anomalies | Medically Necessary when criteria met | 93303, C8921 | Adult patients ≥18 only; congenital anomaly ICD-10 required |
| Follow-up or limited TTE for congenital anomalies | Medically Necessary when criteria met | 93304, C8922 | Requires documentation supporting limited vs. complete study |
| Complete TTE with Doppler and color flow | Medically Necessary when criteria met | 93306, C8923, C8929 | Most common billing combination; pair with qualifying cardiac ICD-10 |
| TTE without Doppler (complete) | Medically Necessary when criteria met | 93307 | Less common; confirm clinical rationale for omitting Doppler |
| TTE follow-up or limited study | Medically Necessary when criteria met | 93308, C8924 | High denial risk if documentation doesn't support limited scope |
| 3D echocardiographic imaging and postprocessing | Medically Necessary when criteria met | 93319 | Add-on to primary TTE; base code must be covered |
| Doppler — pulsed wave and/or continuous wave | Medically Necessary when criteria met | 93320, 93321 | Add-on codes; require primary TTE on same claim |
| Doppler color flow velocity mapping | Medically Necessary when criteria met | 93325 | Add-on; billed with primary echocardiography codes |
| Myocardial strain imaging (speckle tracking) | Medically Necessary when criteria met | 93356 | Add-on; document clinical reason for strain assessment separately |
| Cardiac infections (bacterial, viral, fungal) | Medically Necessary when criteria met | 93306, 93307 with A39.51, B33.22, B37.6 | Infectious disease consults should generate supporting notes |
| Sepsis with cardiac involvement | Medically Necessary when criteria met | 93306 with A40.x, A41.x series | Sepsis codes alone may not be sufficient — document cardiac involvement |
| Malignancy with cardiac or pericardial involvement | Medically Necessary when criteria met | 93306, 93307 with C38.0–C38.8, C45.2 | Oncology-ordered TTEs need cardio-oncology or cardiology co-sign where applicable |
| TTE with contrast | Medically Necessary when criteria met | C8921–C8924, C8929 | HCPCS codes replace CPT for contrast studies in applicable facility settings |
Cigna Transthoracic Echocardiography Billing Guidelines and Action Items 2026
1. Audit your active TTE charge capture against the February 14, 2026 effective date.
Pull all Cigna TTE claims from the last 90 days. Look for CPT 93306, 93307, 93308, and 93320/93321/93325 combinations. Flag any claims without a supporting ICD-10 from the 444-code list. Those are your denial risk candidates.
2. Confirm add-on code pairs are correctly linked.
CPT codes 93319, 93320, 93321, 93325, and 93356 are add-on codes. They cannot stand alone. If your charge capture is posting them without a base TTE code (93303, 93304, 93306, 93307, or 93308), fix that pairing before the next billing cycle.
3. Train your coders on the ICD-10 specificity this policy demands.
Coding sepsis without documenting cardiac involvement will not satisfy MM 0510. The policy supports A40.x and A41.x series codes, but your documentation has to show why a TTE was clinically indicated for that patient's sepsis presentation. "Rule out endocarditis" documented in the chart is doing real work here.
4. Check prior authorization requirements by plan before scheduling.
Cigna commercial plans are not uniform on prior auth for echocardiography. Call or check Cigna's provider portal for each member's plan before scheduling non-urgent TTEs. This is especially true for follow-up studies under CPT 93308 and congenital follow-ups under CPT 93304 — payers watch repeat studies closely.
5. Separate your HCPCS contrast codes from CPT non-contrast codes in facility billing.
HCPCS codes C8921 through C8929 cover TTE with contrast. CPT codes 93303 through 93308 cover studies without contrast (or where contrast is not the distinguishing factor). In hospital outpatient settings, you bill the HCPCS code. In physician office settings, you bill CPT. Mixing these will generate edits or denials.
6. Document clinical rationale for myocardial strain imaging separately.
CPT 93356 (speckle tracking-derived myocardial strain) is an add-on that Cigna will scrutinize. A generic "echo with strain" order won't cut it. The chart should explain why strain assessment was clinically necessary — chemotherapy monitoring, subclinical LV dysfunction evaluation, or a specific cardiomyopathy workup tied to a covered ICD-10.
7. For oncology-ordered studies, loop in your compliance officer if you're unsure.
The policy covers malignancies including breast cancer (C50.011–C50.922), lung cancer (C34.00–C34.92), lymphomas (C81–C86), and pericardial mesothelioma (C45.2). Cardio-oncology TTEs are legitimate and billable. But if your practice is ordering these without cardiology documentation of cardiac involvement, that's a documentation gap worth reviewing with your compliance officer before a Cigna audit surfaces it.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Transthoracic Echocardiography Under MM 0510
Covered CPT Codes (When Medical Necessity Criteria Are Met)
| Code | Description |
|---|---|
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies; complete |
| 93304 | Transthoracic echocardiography for congenital cardiac anomalies; follow-up or limited study |
| 93306 | Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, complete, with spectral Doppler echocardiography |
| 93307 | Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, complete, without spectral or Doppler echocardiography |
| 93308 | Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, follow-up or limited study |
| 93319 | 3D echocardiographic imaging and postprocessing during transesophageal echocardiography or during transthoracic echocardiography (add-on) |
| 93320 | Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (add-on) |
| 93321 | Doppler echocardiography, pulsed wave and/or continuous wave with spectral display; follow-up or limited study (add-on) |
| 93325 | Doppler echocardiography color flow velocity mapping (add-on) |
| 93356 | Myocardial strain imaging using speckle tracking-derived assessment of myocardial mechanics (add-on) |
Covered HCPCS Codes (When Medical Necessity Criteria Are Met)
| Code | Description |
|---|---|
| C8921 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete |
| C8922 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study |
| C8923 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2D), complete |
| C8924 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2D), follow-up or limited study |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2D), complete, with spectral Doppler and color flow |
Key ICD-10-CM Diagnosis Codes (Selected from 444 Total Covered Codes)
The full list contains 444 ICD-10-CM codes. The table below includes all codes specifically enumerated in the policy data. Ranges noted (e.g., A41.01–A41.9) cover all codes within those bounds.
| Code | Description |
|---|---|
| A18.84 | Tuberculosis of heart |
| A36.81 | Diphtheritic cardiomyopathy |
| A39.50 | Meningococcal carditis, unspecified |
| A39.51 | Meningococcal endocarditis |
| A39.52 | Meningococcal myocarditis |
| A39.53 | Meningococcal pericarditis |
| A40.0 | Sepsis due to streptococcus, group A |
| A40.1 | Sepsis due to streptococcus, group B |
| A40.3 | Sepsis due to Streptococcus pneumoniae |
| A40.8 | Other streptococcal sepsis |
| A40.9 | Streptococcal sepsis, unspecified |
| A41.01–A41.9 | Other sepsis (range) |
| A42.7 | Actinomycotic sepsis |
| A52.00 | Cardiovascular syphilis, unspecified |
| A52.01 | Syphilitic aneurysm of aorta |
| A52.02 | Syphilitic aortitis |
| A52.03 | Syphilitic endocarditis |
| A52.06 | Other syphilitic heart involvement |
| A54.83 | Gonococcal heart infection |
| B00.7 | Disseminated herpesviral disease |
| B33.20–B33.21 | Viral carditis / Viral endocarditis |
| B33.22 | Viral myocarditis |
| B33.23 | Viral pericarditis |
| B33.24 | Viral cardiomyopathy |
| B37.6 | Candidal endocarditis |
| B37.7 | Candidal sepsis |
| B57.0 | Acute Chagas' disease with heart involvement |
| B57.2 | Chagas' disease (chronic) with heart involvement |
| B58.81 | Toxoplasma myocarditis |
| C33 | Malignant neoplasm of trachea |
| C34.00–C34.92 | Malignant neoplasm of bronchus and lung (range) |
| C37 | Malignant neoplasm of thymus |
| C38.0–C38.8 | Malignant neoplasm of heart, mediastinum, and pleura |
| C39.0–C39.9 | Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs |
| C45.2 | Mesothelioma of pericardium |
| C50.011–C50.912 | Malignant neoplasm of breast (range) |
| C50.921–C50.922 | Malignant neoplasm of breast of unspecified site, male |
| C50.A0–C50.A2 | Malignant inflammatory neoplasm of breast |
| C81.00–C81.99, C81.9A | Hodgkin lymphoma (range) |
| C82.00–C82.99, C82.9A | Follicular lymphoma (range) |
| C83.00–C83.99, C83.9A | Non-follicular lymphoma (range) |
| C84.60–C84.69, C84.6A | Anaplastic large cell lymphoma, ALK-positive |
| C84.70–C84.7A, C84.7B | Anaplastic large cell lymphoma, ALK-negative |
| C85.10–C85.99, C85.9A | Other specified and unspecified types of non-Hodgkin lymphoma |
| C86.00–C86.6 | Other specified types of T/NK-cell lymphoma |
364 additional ICD-10-CM codes are covered under this policy. Access the full list at app.payerpolicy.org.
Get the Full Picture for CPT 93303
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.